| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/14/2001 | WO2001028537A3 Bissulfonamide derivatives as enzyme inhibitors |
| 06/14/2001 | WO2001017537A3 Methods and compositions for reducing immune response |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | WO2000068413A8 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 06/14/2001 | US20010003748 Cycloalky or heterocyclic substituted phenethyl-thiourea compounds used as inhibitor of reverse transcriptase and effective agents for HIV infection treatment, including mutant, drug sensitive or drug resistant strains of HIV |
| 06/14/2001 | US20010003744 Therapeutic compounds |
| 06/14/2001 | US20010003742 Antilipemic formulation |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2396513A1 Pseudomycin phosphate prodrugs |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2393960A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393737A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 06/14/2001 | CA2393688A1 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393644A1 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | CA2393601A1 Antiviral medication |
| 06/14/2001 | CA2393587A1 Use of an immunosuppressant for increasing an antifungal activity of a lipopeptide |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393530A1 Pharmaceutical compositions for oral use |
| 06/14/2001 | CA2393526A1 Nucleic acid delivery system |
| 06/14/2001 | CA2393454A1 Infection of eukaryotic cells with viruses in vitro |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2362649A1 Antibodies binding to human trypsin-like protease and methods for utilizing the same |
| 06/14/2001 | CA2362606A1 Therapeutic antimicrobial compositions |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106604A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/13/2001 | EP1105518A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 06/13/2001 | EP1105513A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 06/13/2001 | EP1105497A1 Cold-adapted equine influenza viruses |
| 06/13/2001 | EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/13/2001 | EP1105483A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105467A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 06/13/2001 | EP1105422A1 Hepatitis c inhibitor peptides |
| 06/13/2001 | EP1105418A1 Vanadate resistance glycosylation 4 gene |
| 06/13/2001 | EP1105413A2 Hepatitis c inhibitor tri-peptides |
| 06/13/2001 | EP1105412A1 Serine protease inhibitors comprising alpha-keto heterocycles |
| 06/13/2001 | EP1105411A1 nrdE |
| 06/13/2001 | EP1105407A2 Aminosterol compounds and uses thereof |
| 06/13/2001 | EP1105395A1 Photocyclized rapamycins |
| 06/13/2001 | EP1105390A2 New compounds |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105159A2 Lt and ct in parenteral immunization methods against helicobacter infection |
| 06/13/2001 | EP1105157A1 Protein delivery system using human papillomavirus virus-like particles |
| 06/13/2001 | EP1105156A1 Non-virulent porphyromonas gingivalis mutant |
| 06/13/2001 | EP1105154A1 Bacterial superantigen vaccines |
| 06/13/2001 | EP1105135A1 Antiviral indoleoxoacetyl piperazine derivatives |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105121A1 Ascorbate-isoquercetin compositions |
| 06/13/2001 | EP1105097A2 Targeted vesicular constructs for cytoprotection and treatment of h.pylori infections |
| 06/13/2001 | EP0854875B1 New cephem compounds |
| 06/13/2001 | EP0789581B1 Method for the prevention and treatment of bovine mastitis |
| 06/13/2001 | EP0690864B1 Crystalline ceftiofur free acid |
| 06/13/2001 | EP0688331B1 New sulfated lyso-ganglioside derivatives |
| 06/13/2001 | DE19957838A1 Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden Gene therapy of HIV-infected individuals by expression of membrane-anchored gp41 peptides |
| 06/13/2001 | DE19955634A1 Kupplungs-Kondensations-Synthese von Heterocyclen Clutch condensation synthesis of heterocycles |
| 06/13/2001 | CN1299368A Improvement in macrolide prodn. |
| 06/13/2001 | CN1299367A 2''-deoxy hygromycin derivatives |
| 06/13/2001 | CN1299365A Hygromycin A derivatives |
| 06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
| 06/13/2001 | CN1299288A Combined vaccine compositions |
| 06/13/2001 | CN1299287A Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 06/13/2001 | CN1299285A Recombinant human interferon beta-1A (IFN-beta-1A) formulation |
| 06/13/2001 | CN1299277A Pharmaceutical compositions contg. the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy] acetate |
| 06/13/2001 | CN1299273A Sticking plaster for controlled release of natural interferon |
| 06/13/2001 | CN1298871A 3-(fatty acid)-1,2 glceride disulfate and its preparing process and application |
| 06/13/2001 | CN1298740A Medicinal composition for treating bone fracture, injury and rheumatism |
| 06/13/2001 | CN1298731A Process for preparing 'Qianjin' capsule to treat ganopathy |
| 06/13/2001 | CN1298730A Process for preparing 'Qianjin' capsule to treat genopathy |
| 06/13/2001 | CN1298716A Medicine containing pittosporum glabratum lindl extract as active components for curing pulmonary tuberculosis |
| 06/13/2001 | CN1298714A Medicine for treating hog cholera |
| 06/13/2001 | CN1298711A Process for preparing medical liquid 'Fujinjing' for cleaning skin |
| 06/13/2001 | CN1298710A Process for preparing exterior-applied plaster |
| 06/13/2001 | CN1298708A Artifical 'Renzhongbai' (people urine sediment) |
| 06/13/2001 | CN1298706A Kelarmycin eye drops and its preparing process |
| 06/13/2001 | CN1298704A Composite lifuding and preparing process |
| 06/13/2001 | CN1067082C Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 06/13/2001 | CN1067078C 2-beta-alkenyl penam sulfones, prepn. method and use thereof |
| 06/13/2001 | CN1067077C Erythromycin derivant and prepn. method and usage of medicine thereof |
| 06/13/2001 | CN1067074C Carbapenem antibiotic, composition and method of prepn. |
| 06/13/2001 | CN1067053C Process for preparing intermediate of derivatives of monocyclic beta-lactam antibiotics |
| 06/13/2001 | CN1066951C Patent traditional Chinese medicine for treating tuberculosis and hepatosis |
| 06/12/2001 | US6245892 Invaplex from gram negative bacteria, method of purification and methods of use |
| 06/12/2001 | US6245813 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245789 HIV and viral treatment |
| 06/12/2001 | US6245788 Using 5-aryl-1,2,4-triadazol-3-yl (thio)urea compound |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245749 Nucleosides with anti-hepatitis B virus activity |
| 06/12/2001 | US6245745 Bactericides and antiprotozoa agents |